Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 197

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 197
---
 Financial Officer at TurboGen. From January of 2007 and until June of 2019 Mr.Iohan was a Partner, Entertainment & Media Industry Leader at PwC Israel, and served as a staff member in various roles at PwC Israel from January 1998 to December 2006. Mr.Iohan is a Certified Public Accountant (CPA), Israel and US (California). He has a B.A. in Accounting and Economics, and an MBA in Finance and Information Technologies, both from the Tel -AvivUniversity. Liora Oren, Independent Director Ms. Liora Oren has served as Kadimastem’s director and chair of the audit committee since September 2022. Ms. Oren brings with her 20 years of financial experience in various companies including the Bio -TechIndustry, and multinational companies traded on the NYSE and the NASDAQ. She has served the director of Finance at Valens Semiconductor since August 2024, and as its corporate controller from August 2021 until August 2024. From May 2017 until August 2021, she served a Financial Controller at Dip -Tech, A Ferro company, Digital Ceramic In -GlassPrinting. From July 2010 until March 2017 Mrs. Oren served as a Finance Director at CFO Direct. From June 2006 until June 2010, she served as a Financial Controller for Africa -IsraelInvestments. She was a Senior Auditor at KPMG from March 2004 until June 2006. She began her professional career as a Budget Controller for the Israeli Defense Forces in March 1999 until March 2004. Ms. Oren is a Certified Public Accountant (CPA), in Israel, she holds a B.A. in accounting and economics from Tel -AvivUniversity and M.A. in law from Bar -IlanUniversity. Tammy Galili, Director Tammy Galili has served as a director at Kadimastem since July 2021. She has three decades of experience in various management positions in the pharmaceutical space. She served as the CEO of Ilex Medical Ltd. from January 2016 and until October 2024, and previously served as the company’s Deputy CEO from January 2014 until January 2014, and Vice President of Sales and Marketing from January 2010 until December 2013. Ms. Galili has an MBA in Healthcare Innovation from Reichman University in Herzliya and a BA in Philosophy and